Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New drugs for epilepsy

J W Sander1

  • 1Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK. Isander@ion.ucl.ac.uk

Current Opinion in Neurology
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

New antiepileptic drugs offer limited seizure freedom and unproven long-term safety. A rational, clinically relevant approach to antiepileptic drug development is urgently needed for better epilepsy treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

African leadership in brain diplomacy: The Yaoundé declaration advances the global brain economy playbook for better brain health.

Neuroscience·2025
Same author

High prevalence of epilepsy in Southern and Northern Rwanda: Myth or reality?

Tropical medicine & international health : TM & IH·2024
Same author

Late-life terminal seizure freedom in drug-resistant epilepsy: "Burned-out epilepsy".

Journal of the neurological sciences·2021
Same author

The impact of COVID-19 on epilepsy care: Perspectives from UK healthcare workers.

Epilepsy & behavior reports·2021
Same author

Comparing two classification schemes for seizures and epilepsy in rural China.

European journal of neurology·2018
Same author

Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.

European journal of neurology·2018

Area of Science:

  • Pharmacology
  • Neurology
  • Clinical Trials

Background:

  • Achieving complete seizure freedom with no side-effects remains the primary goal in epilepsy treatment.
  • Newly marketed antiepileptic drugs (AEDs) have largely failed to meet expectations for chronic epilepsy management.
  • Existing treatments present side-effect challenges, and the long-term safety of newer options is not yet established.

Purpose of the Study:

  • To review newly marketed antiepileptic drugs.
  • To highlight the limitations of current antiepileptic treatment strategies and drug development processes.
  • To advocate for a new, rational approach to antiepileptic drug development and clinical evaluation.

Main Methods:

  • Literature review of newly marketed antiepileptic drugs.

Related Experiment Videos

  • Analysis of current antiepileptic drug development paradigms.
  • Critical assessment of clinical trial designs in epilepsy research.

    • Main Results:

    • Few patients achieve seizure freedom with current antiepileptic drugs.
    • Newly approved AEDs demonstrate limited efficacy in chronic epilepsy.
    • Concerns exist regarding the long-term safety and side-effect profiles of newer AEDs.

    Conclusions:

    • Current antiepileptic drug treatments are inadequate, necessitating a paradigm shift.
    • A rational approach to antiepileptic drug development, focusing on clinical relevance, is essential.
    • Clinical trial programs require redesign to incorporate more relevant paradigms beyond regulatory requirements.